The Biden government is reportedly planning to give Americans over the age of 50 the option of receiving a second booster dose of COfid-19 vaccines from the Pfizer-BioNTech or Moderna vaccines. The New York Times reported on Friday that the move would be made without “strongly recommending” that the group acquire one, citing “several people who know the plan”. FAUCHI SAYS HE DOES NOT EXPECT GREAT COVID-19 EXPLOSION IN US However, the publication noted that “great uncertainties have complicated the decision”, including how long the protection from the second aid will last, as well as how to present the general goal of the White House to the public. Politico said Wednesday that the booster may be recommended for adults 65 and older and that health officials have looked at recent data showing that the vaccine’s effectiveness is declining. FILE – A syringe is made with the Pfizer COVID-19 vaccine at a vaccination clinic at Keystone First Wellness Center in Chester, Pa., December 15, 2021. (AP Photo / Matt Rourke, Archive) In addition, there is the question of timing and whether we should wait until a possible new wave powered by variation threatens the US – especially as pandemic relief funds dwindle. In an interview last Monday on “In the Bubble with Andy Slavitt,” White House COVID-19 coordinator Jeff Zienz said there was currently no funding for the fourth installment. “Right now, we do not have enough money for fourth installments, if needed – shotguns, extra shotguns for all Americans. We do not have the funding, if we needed a vaccine for a particular variant in the future. more than very effective monoclonal therapies “, he said. CDC SAYS SUB-VARIABLE BA.2 OMICRON ACCOUNTS FOR ABOUT 35% OF COVID-19 VARIATIONS IN US “Already, we have had to cut lending to our state partners by 30%, so we maintain the stock we have,” Zients added, calling on Congress to take action. That said, the Times reported that people familiar with the discussions said the Food and Drug Administration (FDA) could approve a second boost as early as next week. Although studies have shown that vaccines for COVID-19 are less effective against the micron variant that causes concern, they still provide strong protection against serious disease and early research shows that they seem just as effective against the BA.2 subtype that spreads to Worldwide. And while Moderna, Pfizer and BioNTech have called for urgent authorization for second boost shots – Moderna for all adults – the Times wrote that no meetings of the FDA or Centers for Disease Control and Prevention (CDC) Advisory Board have been scheduled before decision. CLICK HERE TO RECEIVE THE FOX NEWS APPLICATION The FDA Advisory Committee will meet in April to discuss what the overall vaccine strategy should be for the Biden administration during the third year of the pandemic. CDC figures show that 217.3 million Americans are fully vaccinated and 97.1 million have received a booster.
